JAN RODA: Open Payments
NPI 1386619492 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,946 in 64 payments from 6 companies in 2025. Trend: 2023 $1,786 · 2024 $2,646 · 2025 $2,946
Food & beverage: $2,946
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $1,256 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $497 |
| Vanda Pharmaceuticals Inc. | 20 | $474 |
| Otsuka America Pharmaceutical, Inc. | 5 | $296 |
| Axsome Therapeutics, Inc. | 2 | $246 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $176 |
Products named: VRAYLAR, CAPLYTA, FANAPT, REXULTI, Auvelity, TRINTELLIX.
Industry payments across NY — which companies pay providers there.
